Novartis To Pay $12.3M, Royalties To End IP Row With Juno
Novartis Pharmaceuticals Corp. will pay $12.25 million and royalties to Juno Therapeutics Inc. to settle a three-year-old patent dispute over cancer immunotherapy drugs between a university and a hospital with which...To view the full article, register now.
Already a subscriber? Click here to view full article